The Pharma Data

FEBRUARY 25, 2021

Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2019 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site ( www.sec.gov ).

Production 52

Production Containment Regulation Manufacturing 52

The Pharma Data

DECEMBER 3, 2020

Copies of the registration statements can be accessed through the SEC’s website at www.sec.gov. Registration statements relating to these securities have been filed with the Securities and Exchange Commission (SEC) and became effective on December 3, 2020.

Sales 40

Sales Marketing Development 40

The Pharma Data

MARCH 25, 2021

The complete terms and conditions are set out in the Offer to Purchase, which was filed with the SEC today, March 25, 2021. the Information Agent for the offer, toll free at (800) 322-2885 (or please call (212) 929-5500 if you are located outside the U.S. or Canada) or via email at tenderoffer@mackenziepartners.com.

Containment 52

Containment 52

The Pharma Data

FEBRUARY 22, 2021

Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. The forward-looking statements in the webcast speak only as of the original date of the webcast.

Production 52

Production Manufacturing Development Vaccination 52

The Pharma Data

SEPTEMBER 11, 2020

Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Production 52

Production Manufacturing Vaccination Vaccine 52

The Pharma Data

AUGUST 31, 2020

Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Risk Factors,” and in the company’s most recently filed Quarterly Report on Form 10-Q, and the company’s subsequent filings with the Securities and Exchange Commission.

Vaccination 52

Vaccination Vaccine Containment Production 52

The Pharma Data

NOVEMBER 19, 2020

You may obtain free copies of the definitive proxy statement/prospectus and other relevant documents filed by Petros and Neurotrope with the SEC at the SEC’s website at www.sec.gov. 1185 Avenue of the Americas, 3rd Floor, New York, New York 10036, Attention: Robert Weinstein. Participants in the Solicitation.

Containment 52

Containment Marketing Sales Clinical Trials 52

Pfizer

FEBRUARY 9, 2023

Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. For a discussion of these and other risks and uncertainties, see BioNTech’s Quarterly Report on Form 6-K for the quarter ended September 30, 2022, filed with the SEC on November 7, 2022, which is available on the SEC’s website at www.sec.gov.

Vaccination 75

Vaccination Vaccine Clinical Trials Clinical Trials 75

The Pharma Data

SEPTEMBER 12, 2020

Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. For a discussion of these and other risks and uncertainties, see BioNTech’s Annual Report on Form 20-F filed with the SEC on March 31, 2020, which is available on the SEC’s website at www.sec.gov. About BioNTech.

Vaccination 52

Vaccination Vaccine Trials Clinical Trials 52

The Pharma Data

NOVEMBER 10, 2020

Additional information concerning these and other risk factors affecting Calithera’s business can be found in Calithera’s most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission, and other periodic filings with the Securities and Exchange Commission at www.sec.gov.

Production 40

Production Clinical Trials Clinical Trials Development 40

The Pharma Data

OCTOBER 27, 2020

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and actual results may differ materially from those suggested by these forward-looking statements.

Containment 40

Containment Scientist Research Marketing 40

The Pharma Data

JANUARY 26, 2021

Securities and Exchange Commission website at www.sec.gov. The offering is being made only by means of an offering circular, copies of which may be obtained, when available, by contacting: The Benchmark Company, LLC, Attention: Prospectus Department, 150 E. The offering circular is also available on the U.S.

Gene Therapy 52

Gene Therapy Gene Silencing Gene Containment 52

The Pharma Data

JANUARY 5, 2021

A prospectus supplement and the accompanying prospectus relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC’s website at www.sec.gov.

Sales 52

Sales Gene Therapy Clinical Trials Clinical Trials 52

Pfizer

JANUARY 17, 2023

Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. Pfizer Media Contact: . +1 1 (212) 733-1226 PfizerMediaRelations@pfizer.com . Pfizer Investor Contact: Investor Relations . +1 1 (212) 733-4848 IR@pfizer.com.

Manufacturing 85

Manufacturing Containment Development Medicine 85

The Pharma Data

SEPTEMBER 22, 2020

Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Production 52

Production Manufacturing Vaccination Vaccine 52

The Pharma Data

AUGUST 6, 2020

Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Business Development 52

Business Development Production Manufacturing Development 52

Pfizer

OCTOBER 18, 2022

Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments. .

Vaccination 40

Vaccination Vaccine Gene Therapy Medicine 40

The Pharma Data

JULY 15, 2021

The documents filed by AstraZeneca with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov. The documents filed by Alexion with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov.

Marketing 52

Marketing Containment Regulation Medicine 52

The Pharma Data

JULY 6, 2021

The documents filed by AstraZeneca with the SEC may be obtained free of charge at the SEC’s website at www.sec.gov.

Containment 52

Containment Regulation Medicine Marketing 52

Pfizer

JUNE 30, 2022

Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. # # #. Media Contact: PfizerMediaRelations@Pfizer.com. +1 1 (212) 733-1226. . Investor Contact: IR@Pfizer.com. +1 1 (212) 733-4848. Responsibility. Recent Announcements. 07.13.2022.

Containment 75

Containment Vaccination Vaccine Development 75

The Pharma Data

DECEMBER 28, 2020

You can locate these reports through the Company’s website at [link] and on the SEC’s website at www.sec.gov. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in Amphastar’s filings with the Securities and Exchange Commission.

Bioequivalency 52

Bioequivalency Production Sales Marketing 52

The Pharma Data

DECEMBER 13, 2020

When available, copies of the prospectus supplement relating to the registered direct offering, together with the accompanying prospectus, can be obtained at the SEC’s website at www.sec.gov or from Maxim Group LLC, 405 Lexington Avenue, New York, NY 10174, Attention: Syndicate Department, or via email at syndicate@maximgrp.com or telephone at (..)

Life Science 52

Life Science Sales Licensing Licensing 52

The Pharma Data

SEPTEMBER 3, 2020

Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Production 52

Production Manufacturing Vaccination Vaccine 52

The Pharma Data

JUNE 16, 2021

Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. The forward-looking statements in the webcast speak only as of the original date of the webcast. Pfizer assumes no obligation to update forward-looking statements contained in the webcast as the result of new information or future events or developments.

Production 40

Production Manufacturing Development Vaccination 40

The Pharma Data

SEPTEMBER 8, 2020

For a discussion of these and other risks and uncertainties, see BioNTech’s Annual Report on Form 20-F filed with the SEC on March 31, 2020, which is available on the SEC’s website at www.sec.gov. Copies of these filings are available online at www.sec.gov , www.jnj.com or on request from Johnson & Johnson.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

The Pharma Data

AUGUST 18, 2020

Copies of these filings are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Risk Factors,” and in the company’s most recently filed Quarterly Report on Form 10-Q, and the company’s subsequent filings with the Securities and Exchange Commission.

Development 52

Development Research Containment Production 52

The Pharma Data

JANUARY 26, 2021

A copy of the Registration Statement may be obtained on the SEC’s website at www.sec.gov. The filing of the Registration Statement does not affect the statutory pre?emption emption rights of shareholders in the Company. Source link.

Life Science 40

Life Science Sales Antibody Marketing 40

The Pharma Data

JANUARY 21, 2021

A preliminary prospectus supplement and accompanying prospectus relating to the offering were filed with the SEC and are available on the SEC’s website at www.sec.gov. The shares of common stock may be offered only by means of a prospectus. Wainwright & Co.,

Containment 52

Containment Sales Production Development 52

The Pharma Data

DECEMBER 10, 2020

A preliminary prospectus supplement and accompanying base prospectus relating to the offering was filed with the SEC on December 10, 2020 and is available on the SEC’s website at www.sec.gov. Wainwright & Co., LLC, 430 Park Avenue, 3rd Floor, New York, NY 10022, via email at placements@hcwco.com or via telephone at (646) 975-6996.

Sales 52

Sales Development Containment Marketing 52

The Pharma Data

DECEMBER 1, 2020

Copies of the prospectus and final prospectus supplement relating to this offering may be obtained, when available, by visiting the SEC’s website at www.sec.gov or contacting the offices of Goldman Sachs & Co. The offering is being made only by means of a prospectus and prospectus supplement.

Sales 40

Sales Marketing Production Development 40

The Pharma Data

DECEMBER 8, 2020

A preliminary prospectus supplement and accompanying prospectus relating to the offering has been filed with the SEC and is available on the website of the SEC at www.sec.gov. When available, copies of the final prospectus supplement and accompanying prospectus relating to the offering may be obtained from: Goldman Sachs and Co.

Containment 52

Containment Sales Marketing Antibody 52

The Pharma Data

NOVEMBER 12, 2020

Five Prime has filed a preliminary prospectus supplement and the accompanying prospectus related to the offering with the SEC, which are available on the SEC’s website, located at www.sec.gov. 6132 or by e-mail at syndicate@svbleerink.com.

Containment 40

Containment Sales Clinical Development Development 40

The Pharma Data

OCTOBER 28, 2020

Readers are advised to review our filings with the SEC, which can be accessed over the Internet at the SEC’s website located at www.sec.gov. We do not plan to update any such forward-looking statements and expressly disclaim any duty to update the information contained in this press release except as required by law.

Containment 40

Containment DNA 40

The Pharma Data

SEPTEMBER 8, 2020

www.sec.gov. www.sec.gov. www.sec.gov. ). www.sec.gov. www.sec.gov. For a discussion of these and other risks and uncertainties, see BioNTech’s Annual Report on Form 20-F filed with the. March 31, 2020. which is available on the SEC’s website at. undertakes no duty to update this information unless required by law.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

The Pharma Data

OCTOBER 15, 2020

Copies of the registration statement can be accessed by visiting the SEC website at www.sec.gov. A registration statement relating to the offering of these securities was declared effective by the Securities and Exchange Commission (the “SEC”) on October 15, 2020.

Containment 40

Containment Dermatology Sales Marketing 40

Pfizer

AUGUST 3, 2022

Securities and Exchange Commission and available at www.sec.gov and www.pfizer.com. Media Relations: +1 (212) 733-1226 PfizerMediaRelations@Pfizer.com. Investor Relations: +1 (212) 733-4848 IR@Pfizer.com. Recent Announcements. 08.03.2022.

Development 101

Development Vaccination Vaccine Production 101

The Pharma Data

JANUARY 20, 2021

A preliminary prospectus supplement and the accompanying prospectus relating to and describing the terms of the offering have been filed with the SEC and are available on the SEC’s website at www.sec.gov.

Sales 40

Sales Genome Genomics Medicine 40